Press-release for stocks for perrigo company for abt

entities : Perrigo company symbols : Abt

save search

Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published: 2024-04-19 (Crawled : 15:00) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| 0.0% | O: -0.13% H: 0.0% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| 0.0% | O: 0.79% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| 0.0% | O: -0.75% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
first treatment for

AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12 (Crawled : 14:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -3.96% | O: -0.13% H: 0.0% C: -2.94%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -3.82% | O: -1.65% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -4.53% | O: -1.06% H: 0.21% C: -1.05%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -4.0% | O: -3.02% H: 0.0% C: 0.0%
drug label astrazeneca expansion for kids

Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 0.01% | O: 2.24% H: 0.0% C: -0.8%
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -4.33% | O: 0.96% H: 1.17% C: 0.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -4.97% | O: -0.48% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -4.32% | O: 0.09% H: 0.16% C: -0.7%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -3.02% | O: 0.84% H: 0.0% C: 0.0%
for

FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -3.54% | O: -1.77% H: 0.0% C: -1.81%
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -4.48% | O: -0.22% H: 0.8% C: 0.06%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -6.72% | O: -1.84% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -3.37% | O: -0.37% H: 1.42% C: 1.37%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -6.35% | O: -3.44% H: 0.0% C: 0.0%
fda for

FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -4.09% | O: -0.29% H: 1.34% C: -0.64%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.1% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -5.02% | O: 0.11% H: 0.37% C: -0.77%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -4.59% | O: 0.69% H: 0.0% C: 0.0%
fda drug schizophrenia

AstraZeneca Kicks Off April With New PNH Approval
Published: 2024-04-02 (Crawled : 13:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -6.45% | O: -1.09% H: 0.13% C: -1.39%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.13% | O: -0.77% H: 0.8% C: 0.74%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -5.08% | O: -0.18% H: 0.47% C: 0.12%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -6.67% | O: -1.14% H: 0.02% C: -1.06%
approval astrazeneca

FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published: 2024-03-29 (Crawled : 19:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| Email alert Add to watchlist
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| Email alert Add to watchlist
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| Email alert Add to watchlist
fda hepatitis kidney anemia

FDA Approves New Treatments for Two Rare Diseases
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -7.26% | O: -0.26% H: 0.0% C: 0.0%
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -2.47% | O: 0.84% H: 1.48% C: 1.29%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -6.86% | O: 0.3% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -3.65% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -7.5% | O: 1.06% H: 0.0% C: 0.0%
fda rare

Regeneron Hit With Two CRLs, J&J’s PAH Treatment Approved
Published: 2024-03-25 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.09% | O: -100.0% H: NaN% C: Infinity%
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -4.09% | O: 0.35% H: 0.35% C: -1.34%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -6.82% | O: 0.04% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -3.77% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.33% | O: 0.42% H: 0.0% C: 0.0%
approved treatment

Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nods for DMD, Hypertension
Published: 2024-03-22 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -2.65% | O: -1.58% H: 0.0% C: 0.0%
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -4.88% | O: 0.35% H: 0.99% C: -1.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -6.81% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -5.0% | O: -0.43% H: 0.41% C: -0.85%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -4.11% | O: 1.47% H: 0.23% C: -0.19%
fda hypertension

Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published: 2024-03-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -2.65% | O: -1.58% H: 0.0% C: 0.0%
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -4.88% | O: 0.35% H: 0.99% C: -1.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -6.81% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -5.0% | O: -0.43% H: 0.41% C: -0.85%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -4.11% | O: 1.47% H: 0.23% C: -0.19%
fda hypertension

FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published: 2024-03-21 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -2.29% | O: 0.14% H: 0.24% C: 0.24%
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -4.03% | O: 0.0% H: 1.6% C: 0.89%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -6.83% | O: -0.03% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -5.53% | O: -0.56% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -3.83% | O: 0.3% H: 0.0% C: 0.0%
fda drug iclusig hypertension

FDA Approves First Gene Therapy for Rare Pediatric Disease
Published: 2024-03-18 (Crawled : 23:00) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -1.09% | O: 0.33% H: 0.13% C: -1.51%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.4% | O: 0.2% H: 0.08% C: -1.14%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -6.18% | O: 1.71% H: 0.36% C: -2.52%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -6.01% | O: -0.81% H: 0.0% C: 0.0%
fda rare first disease therapy

Madrigal’s Rezdiffra, BMS’s Breyanzi Lead Week of Landmark FDA Approvals
Published: 2024-03-15 (Crawled : 15:00) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -2.69% | O: -0.62% H: 0.59% C: -1.01%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.85% | O: -1.58% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -11.37% | O: -5.53% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -6.03% | O: -0.02% H: 0.0% C: 0.0%
fda breyanzi week

FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug ...
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -0.69% | O: 0.0% H: 2.38% C: 1.12%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.8% | O: 0.43% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -11.91% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.31% | O: 0.57% H: 0.0% C: 0.0%
fda drug wegovy approved

FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published: 2024-03-11 (Crawled : 14:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -0.69% | O: 0.0% H: 2.38% C: 1.12%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.8% | O: 0.43% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -11.91% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.31% | O: 0.57% H: 0.0% C: 0.0%
fda drug wegovy approved

FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa
Published: 2024-03-08 (Crawled : 18:00) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology